MNRO

Monro, Inc.

50
Fundamentals54/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential34/ 100

MNRO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE has the edge over MNRO overall, supported by stronger valuation and lower modeled downside.

MNRO Fundamentals

MetricStatus
Stable
Stable
Under pressure
Healthy

MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

MNRO PE Valuation

MNRO has no meaningful PE right now: it lost money over the past year.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.

MNRO Forward outlook

MetricOutlook
--
Turning to a loss
Stable
Weakening
Limited
High

Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

MNRO Risk to reward

ScenarioChangePrice
Upside+50%$15.51
Downside-34%$6.88

Calculated from the latest close: $10.36 on Nov 12.

MNRO has a better modeled risk to reward balance than NKE, with more potential upside relative to its potential downside.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE trails MNRO on modeled risk to reward, with less potential upside relative to its potential downside.

MNRO Earnings Per Share

Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
QuarterTTM EPSYoY
Q3 2026$0.00+$0.69
Q2 2026$0.23+$0.92
Q1 2026$0.03+$0.25
Q4 2025-$0.49-177%
Q3 2025-$0.69-179%
Q2 2025-$0.69-163%
Q1 2025-$0.22-119%
Q4 2024$0.64-41%

MNRO has the edge over NKE on earnings, with more consistent year-over-year improvement.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

MNRO Quarterly Revenue

Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$283.6M-1.8%
Q2 2026$287.1M-4.6%
Q1 2026$273.8M-7.2%
Q4 2025$293.4M-4%
Q3 2025$288.9M-4.1%
Q2 2025$301M+2.7%
Q1 2025$295M-4.9%
Q4 2024$305.8M-3.7%

MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE has the edge over MNRO on sales, with more consistent year-over-year improvement.

MNRO Free Cash Flow

Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
QuarterFree cash flowYoY
Q3 2026$28.8M+8.2%
Q2 2026-$37.9M-$28.6M
Q1 2026$12.4M-47%
Q4 2025$9.1M+15%
Q3 2025$26.6M-54%
Q2 2025-$9.3M-156%
Q1 2025$23.2M+$35.1M
Q4 2024$7.9M-73%

MNRO has the edge over NKE on cash flow, with more consistent year-over-year improvement.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.

MNRO Total Shares

Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
PeriodChange %Net change
Quarterly+3.8%+1.1M shares
1 year-0.2%-68K shares
3 years-3%-977K shares
5 years-8%-2.7M shares
Available history-7.9%-2.7M shares

MNRO has the edge over NKE on shareholder dilution, with a more favorable share count trend.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has 1.5B diluted shares, about the same as a year ago.

MNRO Net Leverage

Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
QuarterNet LeverageStatus
Q3 20261.5xHealthy
Q2 20261.5xHealthy
Q1 20261.0xHealthy
Q4 20251.2xHealthy
Q3 20251.5xHealthy
Q2 20251.7xHealthy
Q1 20251.0xVery low
Q4 20240.8xVery low

MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE has the edge over MNRO on leverage, with a lower net debt burden relative to earnings.

MNRO Weekly Momentum

MetricValueStatus
RSI34.0Neutral
Stochastic5.4Oversold

MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

MNRO PE vs Consumer Cyclical Sector

MetricMNROSector medianRelative
PE58x18x219% above
PE %854738 pts above

MNRO has no meaningful PE right now: it lost money over the past year.

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE has the edge over MNRO on valuation relative to its sector.

MNRO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.718% below
20 week MA$13.523% below
50 week MA$16.437% below
100 week MA$16.838% below
200 week MA$25.159% below

MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has the edge over MNRO on trend strength, trading above more of its moving averages.

MNRO Yearly ROI

YearStart priceEnd priceROI
2020$78.9$53.1-33%
2021$53.1$59.2+11%
2022$59.2$45.2-24%
2023$45.2$29.3-35%
2024$29.3$24.8-16%
2025$24.8$20.8-16%
2026 YTD$20.8$10.4-50%

MNRO has finished four years in a row lower, and it's down 50% so far in 2026.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has the edge over MNRO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key